Mar. 31, 2014 - Spire Corporation announced today revenues from continuing operations for the year ended December 31, 2013 of $14.6 million, a 34% decrease from $22.1 million in 2012. Net loss for the year ended December 31, 2013 was $8.5 million, or $0.92 per diluted share, compared to a net loss of $1.9 million, or $0.22 per diluted share, for the same period of 2012.
These results include the completion of a transaction previously reported in which substantially all of the assets and assumption of certain liabilities related to Spire's biomedical business were acquired by N2 Biomedical, LLC. As this transaction is being identified as giving rise to a variable interest entity and Spire is determined to be the primary beneficiary, the assets, liabilities and results of operations of N2 Biomedical, LLC are consolidated into the Company's financial statements. In addition, the transaction gave rise to a deemed dividend in the amount of $9.5 million which is not reported as a gain for financial reporting purposes and is eliminated in consolidation. Fiscal 2012, net operating results reflect a gain on the sale of its semiconductor business unit of $3.5 million, net of a tax provision of $1.9 million or $0.34 per diluted share.
Spire's revenues from continuing operations for the fourth-quarter ended December 31, 2013 were $3.6 million, a decrease of 5% from $3.8 million in the fourth-quarter of 2012. The decrease was primarily due to sales mix within the solar manufacturing business segment. Net loss for the quarter was $1.9 million, or $0.22 per diluted share, compared to net loss of $1.1 million, or $0.13 per diluted share, for the fourth-quarter of 2012. Spire recorded a net loss from continuing operations of $1.9 million in the fourth-quarter of 2013, compared to a net loss from continuing operations of $1.3 million in the fourth-quarter of 2012.
Gross margin from continuing operations for fiscal year 2013 was $2.5 million, or 17% of revenue, compared to $5.3 million, or 24% of revenue for fiscal year 2012, primarily due to the decline in sales, lower indirect costs offset by the amount of overhead absorbed due to the reduction in sales volume.
Net cash used in operating activities of continuing operations was $5.2 million for the year ended 2013, as compared to net cash used in operating activities of continuing operations of $6.1 million for the same period last year. At year-end 2013, Spire had unrestricted cash and cash equivalents of $4.0 million, as compared to $3.0 million at December 31, 2012.
Rodger W. LaFavre, President and CEO, stated, "While we are seeing improved PV market conditions, they were too late to translate into improved PV equipment sales for the fourth quarter of 2013."
Mr. LaFavre, continued, "Current industry forecasts would indicate that strong demand will stimulate revenues for the industry's manufacturers. We are already seeing increased equipment and turn-key line activities. Our focus on a sustained cost reduction program has resulted in measurable savings in operating expenses and is expected to continue through 2014. We are optimistic that the improving module manufacturing equipment business, combined with our cost reduction efforts will allow Spire to improve its operating performance in 2014."